Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enema is a hypertonic saline solution used as a laxative for bowel preparation.
## Primary Indications
* Bowel cleansing prior to colonoscopy or barium enema.
* Relief of occasional constipation.
## Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 oz (133 mL) bottle is administered as a single dose. For optimal results, follow product instructions regarding timing (e.g., evening before procedure) and potential repeat doses if instructed by the prescriber.
* **Constipation:** One 2.25 oz (66 mL) bottle administered once every 24 hours as needed.
## Pediatric Dosing
* **Constipation:**
* Ages 6-12 years: One 1.125 oz (33 mL) bottle administered once every 24 hours as needed.
* Under 6 years: Use is generally not recommended due to increased risk of electrolyte abnormalities. Consult a pediatrician for alternative options.
## Dose Adjustments
No dose adjustments are typically required based on renal or hepatic impairment, but caution is advised due to the risk of electrolyte disturbances.
## Contraindications
* Congestive heart failure.
* Newly diagnosed or existing kidney disease.
* Abdominal obstruction or severe ileus.
* Congenital megacolon.
* Intestinal perforation or toxic megacolon.
* Children under 2 years of age.
* Patients with impaired rectal absorption or sensitivity to sodium phosphate.
* Concurrent use of other sodium phosphate products or medications that can affect electrolytes or hydration.
## Adverse Effects
* **Common:** Abdominal cramping, bloating, nausea, vomiting, rectal irritation.
* **Serious:**
* **Electrolyte Imbalance:** Hyperphosphatemia, hypocalcemia, hypernatremia, hypokalemia, and metabolic acidosis are significant risks, particularly in children, the elderly, patients with renal impairment, or with repeated use. This can lead to cardiac arrhythmias, seizures, and kidney damage.
* **Dehydration:** Due to osmotic effects.
* **Rectal Mucosal Damage:** Ulceration or perforation, especially with improper administration or repeated use.
* **Renal Injury:** Acute kidney injury and nephrocalcinosis.
## Key Drug Interactions
* **Diuretics:** Increased risk of dehydration and electrolyte imbalance.
* **ACE Inhibitors/ARBs:** Increased risk of hyperkalemia.
* **NSAIDs:** May increase the risk of renal impairment and hyperphosphatemia.
* **Other Laxatives:** Concomitant use can potentiate electrolyte loss and dehydration.
## Monitoring
* Monitor for signs and symptoms of dehydration and electrolyte imbalance (e.g., thirst, dry mouth, decreased urine output, dizziness, muscle cramps, irregular heartbeat).
* Assess for abdominal pain, distension, or lack of bowel movement.
* Consider baseline and post-administration electrolytes and renal function in high-risk patients, especially with repeat use or in pediatric populations.
## Clinical Pearls
* Administer slowly and retain the enema for the recommended duration (typically 5-15 minutes) to ensure effectiveness.
* Encourage fluid intake before and after administration to minimize dehydration.
* Do not use if rectal bleeding is present or if the patient has not had a bowel movement after previous enema use, unless directed by a physician.
* Due to the risk of severe electrolyte disturbances, it is crucial to adhere strictly to the recommended dosage and frequency, particularly in pediatric patients and those with underlying medical conditions.
* Consider alternatives for bowel preparation in patients with contraindications or high risk for complications.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always verify current prescribing information and consult with a qualified healthcare provider for any health concerns or before making any treatment decisions.
